Journal of Clinical Oncology O'Connor, O A, Özcan, M, Jacobsen, E D, Roncero, J M, Trotman, J, Demeter, J, Masszi, T, Pereira, J, Ramchandren, R, Beaven, A, Caballero, D, Horwitz, S M, Lennard, A, Turgut, M, Hamerschlak, N, d'Amore, F A, Foss, F, Kim, W-S, Leonard, J P, Zinzani, P L, Chiattone, C S, Hsi, E D, Trümper, L, Liu, H, Sheldon-Waniga, E, Ullmann, C D, Venkatakrishnan, K, Leonard, E J, Shustov, A R & Lumiere Study Investigators 2019, ' Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma ', Journal of Clinical Oncology, vol. 37, no. 8, pp. 613-623 . https://doi.org/10.1200/JCO.18.00899